{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:37:52Z","timestamp":1787017072548,"version":"build-2736575974"},"reference-count":22,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"unspecified","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003197","name":"Agenzia Italiana del Farmaco, Ministero della Salute","doi-asserted-by":"publisher","award":["FL PI 2016 call"],"award-info":[{"award-number":["FL PI 2016 call"]}],"id":[{"id":"10.13039\/501100003197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2013-02359212"],"award-info":[{"award-number":["GR-2013-02359212"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2016-02364546"],"award-info":[{"award-number":["GR-2016-02364546"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2016-02364388"],"award-info":[{"award-number":["RF-2016-02364388"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministero dell'Istruzione, dell'Universit\u00e0 e della Ricerca","award":["Grant PRIN 2017"],"award-info":[{"award-number":["Grant PRIN 2017"]}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["17184"],"award-info":[{"award-number":["17184"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["20096"],"award-info":[{"award-number":["20096"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["21724"],"award-info":[{"award-number":["21724"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["9962"],"award-info":[{"award-number":["9962"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG-ID 18495 to DF"],"award-info":[{"award-number":["IG-ID 18495 to DF"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2021,1,7]]},"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:p>Immune escape mechanisms employed by neuroblastoma (NB) cells include secretion of immunosuppressive factors disrupting effective antitumor immunity. The use of cellular therapy to treat solid tumors needs to be implemented. Killing activity of anti-GD2 Chimeric Antigen Receptor (CAR) T or natural killer (NK) cells against target NB cells was assessed through coculture experiments and quantified by FACS analysis. ELISA assay was used to quantify interferon-\u03b3 (IFN\u03b3) secreted by NK and CAR T cells. Real Time PCR and Western Blot were performed to analyze gene and protein levels modifications. Transcriptional study was performed by chromatin immunoprecipitation and luciferase reporter assays on experiments of mutagenesis on the promoter sequence. NB tissue sample were analyzed by IHC and Real Time PCR to perform correlation study. We demonstrate that Indoleamine-pyrrole 2,3-dioxygenase1 (IDO1), due to its ability to convert tryptophan into kynurenines, is involved in NB resistance to activity of immune cells. In NB, IDO1 is able to inhibit the anti-tumor effect displayed by of both anti-GD2 CAR (GD2.CAR) T-cell and NK cells, mainly by impairing their IFN\u03b3 production. Furthermore, inhibition of MYCN expression in NB results into accumulation of IDO1 and consequently of kynurenines, which negatively affect the immune surveillance. Inverse correlation between IDO1 and MYCN expression has been observed in a wide cohort of NB samples. This finding was supported by the identification of a transcriptional repressive role of MYCN on IDO1 promoter. The evidence of IDO1 involvement in NB immune escape and its ability to impair NK and GD2.CAR T-cell activity contribute to clarify one of the possible mechanisms responsible for the limited efficacy of these immunotherapeutic approaches. A combined therapy of NK or GD2.CAR T-cells with IDO1 inhibitors, a class of compounds already in phase I\/II clinical studies, could represent a new and still unexplored strategy capable to improve long-term efficacy of these immunotherapeutic approaches.<\/jats:p>","DOI":"10.1136\/jitc-2020-001502","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T13:06:09Z","timestamp":1616072769000},"page":"e001502","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":36,"title":["GD2 redirected CAR T and activated NK-cell-mediated secretion of IFN\u03b3 overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape"],"prefix":"10.1136","volume":"9","clinical-trial-number":[{"clinical-trial-number":"nct03373097","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Matteo","family":"Caforio","sequence":"first","affiliation":[{"name":"Department of Hematology\/Oncology and Gene and Cell Therapy, IRCCS Bambino Ges\u00f9 Children's Hospital, Rome, Italy"},{"name":"Departement of Biochemical Sciences \"A Rossi Fanelli\", Sapienza University of Rome, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Sorino","sequence":"additional","affiliation":[{"name":"SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, Istituto Regina Elena Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9250-0605","authenticated-orcid":false,"given":"Ignazio","family":"Caruana","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology and Gene and Cell Therapy, IRCCS Bambino Ges\u00f9 Children's Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrit","family":"Weber","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology and Gene and Cell Therapy, IRCCS Bambino Ges\u00f9 Children's Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Camera","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology and Gene and Cell Therapy, IRCCS Bambino Ges\u00f9 Children's Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Cifaldi","sequence":"additional","affiliation":[{"name":"Academic Department of Pediatrics (DPUO), IRCCS Bambino Ges\u00f9 Children's Hospistal, Rome, Italy"},{"name":"Department of Clical Sciences and Translational Medicine, University of Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biagio","family":"De Angelis","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology and Gene and Cell Therapy, IRCCS Bambino Ges\u00f9 Children's Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9643-3465","authenticated-orcid":false,"given":"Francesca","family":"Del Bufalo","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology and Gene and Cell Therapy, IRCCS Bambino Ges\u00f9 Children's Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Vitale","sequence":"additional","affiliation":[{"name":"Division of Metabolism and Research Unit of Metabolic Biochemistry, IRCCS Bambino ges\u00f9 Children's Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca Maria","family":"Goffredo","sequence":"additional","affiliation":[{"name":"Division of Metabolism and Research Unit of Metabolic Biochemistry, IRCCS Bambino ges\u00f9 Children's Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"De Vito","sequence":"additional","affiliation":[{"name":"Department of Laboratories, Pathology Unit, IRCCS Bambino Ges\u00f9 Children's Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doriana","family":"Fruci","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology and Gene and Cell Therapy, IRCCS Bambino Ges\u00f9 Children's Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4343-9705","authenticated-orcid":false,"given":"Concetta","family":"Quintarelli","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology and Gene and Cell Therapy, IRCCS Bambino Ges\u00f9 Children's Hospital, Rome, Italy"},{"name":"Departyment of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Fanciulli","sequence":"additional","affiliation":[{"name":"SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, Istituto Regina Elena Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology and Gene and Cell Therapy, IRCCS Bambino Ges\u00f9 Children's Hospital, Rome, Italy"},{"name":"Department of Pediatrics, Sapienza University of Rome, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9838-1520","authenticated-orcid":false,"given":"Valentina","family":"Folgiero","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology and Gene and Cell Therapy, IRCCS Bambino Ges\u00f9 Children's Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,3,18]]},"reference":[{"key":"2025100314013026000_9.3.e001502.1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29077"},{"key":"2025100314013026000_9.3.e001502.2","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014241","article-title":"Myc activation is a hallmark of cancer initiation and maintenance","volume":"4","author":"Gabay","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2025100314013026000_9.3.e001502.3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1053\/j.seminoncol.2014.08.005","article-title":"From monoclonal antibodies to chimeric antigen receptors for the treatment of human malignancies","volume":"41","author":"Caruana","year":"2014","journal-title":"Semin Oncol"},{"key":"2025100314013026000_9.3.e001502.4","first-page":"664","article-title":"Tisagenlecleucel in pediatric patients with acute lymphoblastic leukemia","volume":"16","author":"Maude","year":"2018","journal-title":"Clin Adv Hematol Oncol"},{"key":"2025100314013026000_9.3.e001502.5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20081903","article-title":"Car-T with license to kill solid tumors in search of a winning strategy","volume":"20","author":"Sacchetti","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2025100314013026000_9.3.e001502.6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-05-354449"},{"key":"2025100314013026000_9.3.e001502.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2017.03.024"},{"key":"2025100314013026000_9.3.e001502.8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pharmthera.2018.12.004","article-title":"Targeting indoleamine-2,3-dioxygenase in cancer: scientific rationale and clinical evidence","volume":"196","author":"Ricciuti","year":"2019","journal-title":"Pharmacol Ther"},{"key":"2025100314013026000_9.3.e001502.9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-621474"},{"key":"2025100314013026000_9.3.e001502.10","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1433518","article-title":"Choice of costimulatory domains and of cytokines determines CAR T-cell activity in neuroblastoma","volume":"7","author":"Quintarelli","year":"2018","journal-title":"Oncoimmunology"},{"key":"2025100314013026000_9.3.e001502.11","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2998"},{"key":"2025100314013026000_9.3.e001502.12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13045-015-0134-4","article-title":"TIM-3\/Gal-9 interaction induces IFN\u03b3-dependent IDO1 expression in acute myeloid leukemia blast cells","volume":"8","author":"Folgiero","year":"2015","journal-title":"J Hematol Oncol"},{"key":"2025100314013026000_9.3.e001502.13","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201744871","article-title":"Che-1 is targeted by c-myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia","volume":"19","author":"Folgiero","year":"2018","journal-title":"EMBO Rep"},{"key":"2025100314013026000_9.3.e001502.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(97)00351-0"},{"key":"2025100314013026000_9.3.e001502.15","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.745448"},{"key":"2025100314013026000_9.3.e001502.16","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.226"},{"key":"2025100314013026000_9.3.e001502.17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11912-019-0837-8","article-title":"The role of natural killer cells as a platform for immunotherapy in pediatric cancers","volume":"21","author":"Kimpo","year":"2019","journal-title":"Curr Oncol Rep"},{"key":"2025100314013026000_9.3.e001502.18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00056","article-title":"Natural killer cells and neuroblastoma: tumor recognition, escape mechanisms, and possible novel immunotherapeutic approaches","volume":"5","author":"Bottino","year":"2014","journal-title":"Front Immunol"},{"key":"2025100314013026000_9.3.e001502.19","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6101(01)00038-7"},{"key":"2025100314013026000_9.3.e001502.20","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2017.1320626"},{"key":"2025100314013026000_9.3.e001502.21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/13543776.2018.1441290","article-title":"A patent review of IDO1 inhibitors for cancer","volume":"28","author":"Cheong","year":"2018","journal-title":"Expert Opin Ther Pat"},{"key":"2025100314013026000_9.3.e001502.22","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMoa1911326","article-title":"Emapalumab in children with primary hemophagocytic lymphohistiocytosis","volume":"382","author":"Locatelli","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2020-001502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T21:01:42Z","timestamp":1759525302000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2020-001502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,18]]},"published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1136\/jitc-2020-001502"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2020-001502","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}